SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astrix Laboratories Ltd. (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Astrix Laborator Share Price

BSE Share Price
Not Listed

Astrix Laboratories Ltd. (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Astrix Laborator Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹362 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
46.7
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
-2.75%
Return on Capital Employed (ROCE)
-4.48%
Return on Assets (ROA)
-2.07%
Operating Profit Margin
2.5%
Net Profit Margin
-2.67%
Gross Profit Margin
0.3%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-35.51%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-98.48%
Net Profit Growth (1 Year)
-
-233.75%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹342 Cr.
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
- / -

Astrix Laboratories . (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
ROCE % 3.6%12.7%12.6%16%27.5%17.6%8.2%3.3%-4.5%-

Growth Parameters

Sales 42.7227301380507473438561362362
Sales YoY Gr.-430.8%32.8%26.2%33.4%-6.7%-7.5%28.2%-35.5%-
Adj EPS 8.92938.376131.19141.716.5-7.70
YoY Gr.-223.9%32.1%98.6%72.5%-30.6%-54.2%-60.4%-146.9%-
BVPS (₹) 377.1408.1447.4506.3637.9728.8770.4786.47650
Adj Net
Profit
4.113.117.334.459.341.218.97.5-3.50
Cash Flow from Ops. 3.8-60.211.310-2112515.4-1.88.1-
Debt/CF from Ops. 0-1.16.48-5.300-2.60.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA-1%-8.5%-35.5%
Adj EPS NA-163.3%-144%-146.9%
BVPSNA8.6%1.6%-2.7%
Share Price - - - -

Key Financial Parameters

Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14TTM
Return on
Equity %
2.47.48.915.922.913.35.62.1-10
Op. Profit
Mgn %
21.816.71518.420.915.49.94.92.6NAN
Net Profit
Mgn %
9.55.85.89.111.78.74.31.3-10
Debt to
Equity
00.40.40.40.40000-
Working Cap
Days
01701922032072442522243520
Cash Conv.
Cycle
0611221231401691681382270

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Sales42.71226.72301.15379.93506.80473.01437.79561.11361.86
Operating Expenses + 33.39188.76256.13320.98401.09400.30394.48534.09361.45
Manufacturing Costs4.2126.9346.6250.2656.3718.6720.2528.6440.04
Material Costs26.96150.82194.48245.11326.69333.58330.44449.28284.29
Employee Cost 1.105.418.499.2712.049.2811.5313.6516.14
Other Costs 1.125.616.5516.345.9938.7732.2642.5120.98
Operating Profit 9.3237.9645.0158.95105.7172.7243.3027.020.41
Operating Profit Margin (%) 21.8%16.7%14.9%15.5%20.9%15.4%9.9%4.8%0.1%
Other Income + 0.322.272.032.676.957.511.411.210.93
Exceptional Items 000000000
Interest 0.015.375.306.167.013.500.820.580.24
Depreciation 3.4313.5814.1514.9015.3315.7716.5816.7217.20
Profit Before Tax 6.2021.2827.6040.5690.3360.9627.3010.93-16.11
Tax 2.107.299.8013.8930.7419.848.453.70-6.44
Profit After Tax 4.111417.8026.6759.6041.1218.867.23-9.67
PAT Margin (%) 9.6%6.2%5.9%7.0%11.8%8.7%4.3%1.3%-2.7%
Adjusted EPS (₹)9.130.939.358.9131.790.941.716.0-21.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%

Valuation of Astrix Laborator - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14

Equity and Liabilities

Shareholders Fund + 170.65184.65202.45229.12288.72329.84348.70355.92346.26
Share Capital 4.534.534.534.534.534.534.534.534.53
Reserves 166.13180.13197.92224.60284.19325.31344.17351.40341.73
Debt +065.0672.0380.21110.764.2804.762.17
Long Term Debt065.0672.0380.21110.760000
Short Term Debt000004.2804.762.17
Minority Interest000000000
Trade Payables68.9831.7939.6667.2762.1875.5766.80126.0165.57
Others Liabilities 2.9413.3418.3323.8423.9229.3024.2620.5214.07
Total Liabilities 242.57294.84332.47400.45485.57438.99439.76507.22428.07

Fixed Assets

Net Fixed Assets +159.06151.93153.25146.16139.31135.18125.66111.35102.24
Gross Block162.49168.94184.38192.13200.48211.55218.44220.61231.30
Accumulated Depreciation3.4317.0131.1245.9761.1776.3892.78109.26129.05
CWIP 2.531.500.340.910.201.340.423.170.28
Investments 4.0600000000
Inventories36.7374.0479.9498.38128.2196.0397.04116.9684.31
Trade Receivables33.6350.4178.66131.42208.77189.09194.22245.31212.44
Cash Equivalents 1.310.010.043.410.210.053.270.110.09
Others Assets 5.2516.9520.2420.178.8817.2919.1530.3228.71
Total Assets 242.57294.84332.47400.45485.57438.99439.76507.22428.07

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Cash Flow From Operating Activity + 3.75-60.2311.339.99-21.04124.5915.41-1.828.07
PBT 4.111417.8026.6790.3360.9627.3010.93-16.11
Adjustment 6.0127.9727.8635.4720.2619.5217.5117.6018.29
Changes in Working Capital -6.09-99.96-31.75-43.93-102.5166.78-19.18-14.7111.76
Tax Paid -0.27-2.23-2.57-8.22-29.12-22.67-10.23-15.64-5.86
Cash Flow From Investing Activity + -168.99-1.36-13.75-8.54-7.86-14.55-6.95-5.52-5.27
Capex -164.95-5.45-14.05-8.55-7.87-14.55-6.95-5.52-5.27
Net Investments -4.064.060000000
Others 0.020.030.300.0100000
Cash Flow From Financing Activity + 166.5560.292.451.9225.70-110.20-5.234.18-2.83
Net Proceeds from Shares 166.5500000000
Net Proceeds from Borrowing 000000000
Interest Paid 0-4.77-4.95-4.56-6.43-3.76-0.96-0.58-0.24
Dividend Paid 000000000
Others 065.067.396.4832.13-106.44-4.284.76-2.59
Net Cash Flow 1.31-1.300.033.37-3.20-0.163.23-3.16-0.03

Financial Ratio

PARTICULARSMar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14
Ratios
ROE (%)2.417.889.1912.3623.0213.35.562.05-2.75
ROCE (%)3.6412.6812.5516.0127.4617.578.243.25-4.48
Asset Turnover Ratio0.180.870.971.051.181.051.011.210.8
PAT to CFO Conversion(x)0.91-4.30.640.37-0.353.030.82-0.25N/A
Working Capital Days
Receivable Days282.5065.9077.3099.40118.40149.80157.40140224.20
Inventory Days308.6086.8092.2084.3078.9084.4079.3068.1098.60
Payable Days933.90121.9067.1079.6072.3075.4078.6078.30123

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Astrix Laboratories Ltd. (Amalgamated) FAQs

The current trading price of Astrix Laborator on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Astrix Laborator stood at ₹0.00 Cr

The latest P/E ratio of Astrix Laborator as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Astrix Laborator as of 31-Dec-1969 is 0.00.

The 52-week high of Astrix Laborator is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Astrix Laborator is ₹362 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Astrix Laboratories Ltd. (Amalgamated)

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×